BMJ open

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

International journal of medical informatics

international journal of cardiology heart & vasculature

current medical research and opinion

Clinical cardiology

the western journal of emergency medicine

american journal of clinical oncology

journal of breath research

journal of internal medicine

annals of family medicine

Asian journal of urology

[1] Interventions designed to improve the safety and quality of therapeutic anticoagulation in an inpatient electronic medical record.

[2] The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled Trial.

[3] Clinical precision, accuracy, number and durations of exhalations for a novel electrochemical monitor for exhaled nitric oxide.

[4] Evaluation of the potential impact of pharmacy technician performance of anticoagulation clinic tasks on operational efficiency.

[5] Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer.

[6] The “Warfarin Window” in Pregnancy: The Importance of Half-life

[7] implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation

[8] antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

[9] anticoagulação durante gravidez de mulher portadora de cardiopatia anticoagulation during pregnancy of woman with heart diseases

[10] anticoagulation in the elderly

[11] the new oral anticoagulants for the treatment of venous thromboembolism: a new paradigm shift in antithrombotic therapy

[12] avaliação da anticoagulação natural em pacientes com diabetes mellitus tipo 2 natural anticoagulation evaluation in type 2 diabetes

[13] terapia anticoagulante en fibrilación auricular

[14] use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence

[15] anti-factor xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

[16] Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.

[17] Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis

[18] Calcium Priming of the Central Venous Catheter Prevents a Drop in Ionized Calcium Concentration During Regional Citrate Anticoagulation.

[19] Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial.

[20] Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.

[21] Antiplatelet therapy and anticoagulation in patients with hypertension.

[22] Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children.

[23] Interventions designed to improve the safety and quality of therapeutic anticoagulation in an inpatient electronic medical record.

[24] Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial

[25] The Effect of Warfarin Administration Time on Anticoagulation Stability (INRange): A Pragmatic Randomized Controlled Trial.

[26] Anticoagulation with DOACs: Reliably reversing effect of factor Xa inhibitors with antidote

[27] Evaluation of the potential impact of pharmacy technician performance of anticoagulation clinic tasks on operational efficiency.

[28] regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care

[29] prothrombin complex concentrate for rapid reversal of warfarin anticoagulation to allow neuraxial blockade

[30] intra-procedural anticoagulation protocols for left-sided cardiac ablations: striking a balance between risk and benefit

[31] dorsal spinal chronic subdural hematoma complicating warfarin/asprin anticoagulation therapy: a case report study.

[32] fatal pulmonary hemorrhage after taking anticoagulation medication

[33] anticoagulação durante gravidez de mulher portadora de cardiopatia anticoagulation during pregnancy of woman with heart diseases

[34] anticoagulation in the elderly

[35] anticoagulation dilemma in a high-risk patient with on-x valves

[36] oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies

[37] spontaneous suprachoroidal hemorrhage due to the excessive anticoagulation therapy. case report

[38] spontaneous epiglottic hematoma secondary to supratherapeutic anticoagulation

[39] avaliação da anticoagulação natural em pacientes com diabetes mellitus tipo 2 natural anticoagulation evaluation in type 2 diabetes

[40] telephone-based anticoagulation management in the homebound setting: a retrospective observational study

[41] left atrial appendage closure in atrial fibrillation: a world without anticoagulation?

[42] anticoagulation therapy with bemiparin in combination treatment of patients with diabetic peripheral neuropathy and latent ischemia of lower limb tissues

[43] triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment

[44] varfarina e femprocumona: experiência de um ambulatório de anticoagulação warfarina y femprocumona: experiencia de una unidad de anticoagulación warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic

[45] atrial fibrillation ablation without interruption of anticoagulation

[46] Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study

[47] Anticoagulation options for intermittent haemodialysis

[48] Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

[49] Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.

[50] Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

[51] What are the anticoagulation options for intermittent hemodialysis? - Nature Reviews Nephrology

[52] Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

[53] Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study - Annals of Intensive Care

[54] Regional citrate anticoagulation for intermittent predilution online hemofiltration

[55] Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?

[56] Perioperative anticoagulation and open distal corpora cavernosa shunt in the management of a case of stuttering idiopathic persistent childhood ischaemic priapism

[57] Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?

[58] Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.

[59] Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillation.